abstract |
(57) [Summary]nThe present invention relates to compositions and methods for treating CMV infection. Provided are antisense oligonucleotides that are effective antiviral agents. In a preferred embodiment, the oligonucleotide contains at least one 2'-methoxyethoxy modification and may be a chimeric oligonucleotide. |